{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:11:56Z","timestamp":1776057116162,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T00:00:00Z","timestamp":1283904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10620-010-1393-0","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T16:24:03Z","timestamp":1283876643000},"page":"1082-1089","source":"Crossref","is-referenced-by-count":16,"title":["Pioglitazone: A Promising Therapeutic Tool in Sodium Taurocholate-Induced Severe Acute Pancreatitis"],"prefix":"10.1007","volume":"56","author":[{"given":"Ping","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Quan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,8]]},"reference":[{"issue":"4","key":"1393_CR1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1445-2197.2004.02958.x","volume":"74","author":"DT Chiang","year":"2004","unstructured":"Chiang DT, Anozie A, Fleming WR, et al. Comparative study on acute pancreatitis management. ANZ J Surg. 2004;74(4):218\u2013221.","journal-title":"ANZ J Surg"},{"issue":"9173","key":"1393_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(98)10364-1","volume":"354","author":"J Vamecq","year":"1999","unstructured":"Vamecq J, Latruffe N. Medical significance of peroxisome proliferators-activated receptors. Lancet. 1999;354(9173):141\u2013148.","journal-title":"Lancet"},{"issue":"1\u20132","key":"1393_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1011927113563","volume":"224","author":"R Rahimian","year":"2001","unstructured":"Rahimian R, Masih-Khan E, Lo M, et al. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob\/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem. 2001;224(1\u20132):29\u201337.","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"1393_CR4","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1745-7254.2006.00359.x","volume":"27","author":"R Yin","year":"2006","unstructured":"Yin R, Dong YG, Li HL. PPAR gamma phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation. Acta Pharmacol Sin. 2006;27(9):1146\u20131152.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"1393_CR5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1165\/ajrcmb.24.6.4376","volume":"24","author":"AC Wang","year":"2001","unstructured":"Wang AC, Dai X, Luu B, et al. Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation. Am J Respir Cell Mol Biol. 2001;24(6):688\u2013693.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"1393_CR6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0016-5085(03)00262-2","volume":"124","author":"K Katayama","year":"2003","unstructured":"Katayama K, Wada K, Nakajima A, et al. A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology. 2003;124(5):1315\u20131324.","journal-title":"Gastroenterology"},{"issue":"6662","key":"1393_CR7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","volume":"391","author":"C Jiang","year":"1998","unstructured":"Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391(6662):82\u201386.","journal-title":"Nature"},{"issue":"6662","key":"1393_CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","volume":"391","author":"M Ricote","year":"1998","unstructured":"Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391(6662):79\u201382.","journal-title":"Nature"},{"issue":"12","key":"1393_CR9","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.4049\/jimmunol.171.12.6827","volume":"171","author":"B Zingarelli","year":"2003","unstructured":"Zingarelli B, Sheehan M, Hake PW, et al. Peroxisome proliferator activated receptor-gamma ligands, 15-deoxy-Delta(12, 14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol. 2003;171(12):6827\u20136837.","journal-title":"J Immunol"},{"issue":"3","key":"1393_CR10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/jpet.102.047217","volume":"306","author":"N Enomoto","year":"2003","unstructured":"Enomoto N, Takei Y, Hirose M, et al. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone. J Pharmacol Exp Ther. 2003;306(3):846\u2013854.","journal-title":"J Pharmacol Exp Ther"},{"issue":"40","key":"1393_CR11","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.3748\/wjg.v11.i40.6322","volume":"11","author":"PC Konturek","year":"2005","unstructured":"Konturek PC, Dembinski A, Warzecha Z, et al. Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulean-induced pancreatitis. World J Gastroenterol. 2005;11(40):6322\u20136329.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1393_CR12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9610(97)89568-2","volume":"171","author":"CB Hughes","year":"1996","unstructured":"Hughes CB, Grewal HP, Gaber LW, et al. Anti-TNF alpha therapy improves survival and ameliorates the pathophysiologic saquelae in acute pancreatitis in the rat. Am J Surg. 1996;171(2):274\u2013280.","journal-title":"Am J Surg"},{"issue":"1","key":"1393_CR13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00000658-199201000-00007","volume":"215","author":"J Schmidt","year":"1992","unstructured":"Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992;215(1):44\u201356.","journal-title":"Ann Surg"},{"issue":"13","key":"1393_CR14","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3748\/wjg.v13.i13.1983","volume":"13","author":"P Xu","year":"2007","unstructured":"Xu P, Zhou XJ, Chen LQ, et al. Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World J Gastroenterol. 2007;13(13):1983\u20131988.","journal-title":"World J Gastroenterol"},{"issue":"40","key":"1393_CR15","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.3748\/wjg.v12.i40.6458","volume":"12","author":"E Folch-Puy","year":"2006","unstructured":"Folch-Puy E, Granell S, Iovanna JL, et al. Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats. World J Gastroenterol. 2006;12(40):6458\u20136463.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1393_CR16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00006676-200307000-00009","volume":"27","author":"K Hashimoto","year":"2003","unstructured":"Hashimoto K, Ethridge RT, Saito H, et al. The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis. Pancreas. 2003;27(1):58\u201366.","journal-title":"Pancreas"},{"issue":"5","key":"1393_CR17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00134-004-2180-1","volume":"30","author":"S Cuzzocrea","year":"2004","unstructured":"Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. Intensive Care Med. 2004;30(5):951\u2013956.","journal-title":"Intensive Care Med"},{"issue":"2","key":"1393_CR18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arcmed.2008.11.004","volume":"40","author":"C Chen","year":"2009","unstructured":"Chen C, Xu S, Wang WX, et al. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Arch Med Res. 2009;40(2):79\u201388.","journal-title":"Arch Med Res"},{"issue":"219","key":"1393_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365529609104999","volume":"31","author":"AC Beaux De","year":"1996","unstructured":"De Beaux AC, Fearon KC. Circulating endotoxin, tumor necrosis factor-alpha, and their natural antagonists in the pathophysiology of acute pancreatitis. Scand J Gastroenterol. 1996;31(219):43\u201346.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"1393_CR20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/bjs.1800830317","volume":"83","author":"AC Beaux De","year":"1996","unstructured":"De Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996;83(3):349\u2013353.","journal-title":"Br J Surg"},{"issue":"5","key":"1393_CR21","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/gast.1997.v113.pm9352880","volume":"113","author":"W Denham","year":"1997","unstructured":"Denham W, Yang J, Fink G, et al. Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology. 1997;113(5):1741\u20131746.","journal-title":"Gastroenterology"},{"issue":"3","key":"1393_CR22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/gast.1997.v112.pm9041259","volume":"112","author":"AJ Rongione","year":"1997","unstructured":"Rongione AJ, Kusske AM, Kwan K, et al. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology. 1997;112(3):960\u2013967.","journal-title":"Gastroenterology"},{"issue":"34","key":"1393_CR23","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.3748\/wjg.v11.i34.5309","volume":"11","author":"R Laveda","year":"2005","unstructured":"Laveda R, Martinez J, Munoz C, et al. Different profile of cytokine synthesis according to the severity of acute pancreatitis. World J Gastroenterol. 2005;11(34):5309\u20135313.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1393_CR24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gut.43.3.408","volume":"43","author":"JL Laethem Van","year":"1998","unstructured":"Van Laethem JL, Eskinazi R, Louis H, et al. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut. 1998;43(3):408\u2013413.","journal-title":"Gut"},{"issue":"8","key":"1393_CR25","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.4049\/jimmunol.173.8.5196","volume":"173","author":"S Giri","year":"2004","unstructured":"Giri S, Rattan R, Singh AK, et al. The 15-deoxy-delta 12, 14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. J Immunol. 2004;173(8):5196\u20135208.","journal-title":"J Immunol"},{"issue":"13","key":"1393_CR26","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/MCB.20.13.4699-4707.2000","volume":"20","author":"M Li","year":"2000","unstructured":"Li M, Pascual G, Glass CK. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol. 2000;20(13):4699\u20134707.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1393_CR27","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1152\/ajpendo.00205.2003","volume":"286","author":"K Feingold","year":"2004","unstructured":"Feingold K, Kim MS, Shigenaga J, et al. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am J Physiol Endocrinol Metab. 2004;286(2):E201\u2013E207.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"1393_CR28","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1210\/en.138.7.3073","volume":"138","author":"MR Hill","year":"1997","unstructured":"Hill MR, Young MD, McCurdy CM, et al. Decreased expression of murine PPARgamma in adipose tissue during endotoxemia. Endocrinology. 1997;138(7):3073\u20133076.","journal-title":"Endocrinology"},{"issue":"6","key":"1393_CR29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s001250051218","volume":"42","author":"T Tanaka","year":"1999","unstructured":"Tanaka T, Itoh H, Doi K, et al. Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia. 1999;42(6):702\u2013710.","journal-title":"Diabetologia"},{"issue":"8","key":"1393_CR30","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.gassur.2006.04.027","volume":"10","author":"MD Rollins","year":"2006","unstructured":"Rollins MD, Sudarshan S, Firpo MA, et al. Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. J Gastrointest Surg. 2006;10(8):1120\u20131130.","journal-title":"J Gastrointest Surg"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1393-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1393-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1393-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:43:01Z","timestamp":1559230981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1393-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1393-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,8]]}}}